IBDEI1ES ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22786,0)
 ;;=L98.8^^76^978^41
 ;;^UTILITY(U,$J,358.3,22786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22786,1,3,0)
 ;;=3^Skin/Subcutaneous Tissue Disorders
 ;;^UTILITY(U,$J,358.3,22786,1,4,0)
 ;;=4^L98.8
 ;;^UTILITY(U,$J,358.3,22786,2)
 ;;=^5009594
 ;;^UTILITY(U,$J,358.3,22787,0)
 ;;=B35.1^^76^979^9
 ;;^UTILITY(U,$J,358.3,22787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22787,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,22787,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,22787,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,22788,0)
 ;;=F63.3^^76^979^12
 ;;^UTILITY(U,$J,358.3,22788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22788,1,3,0)
 ;;=3^Trichotillomania
 ;;^UTILITY(U,$J,358.3,22788,1,4,0)
 ;;=4^F63.3
 ;;^UTILITY(U,$J,358.3,22788,2)
 ;;=^5003643
 ;;^UTILITY(U,$J,358.3,22789,0)
 ;;=B35.2^^76^979^6
 ;;^UTILITY(U,$J,358.3,22789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22789,1,3,0)
 ;;=3^Tinea Manuum
 ;;^UTILITY(U,$J,358.3,22789,1,4,0)
 ;;=4^B35.2
 ;;^UTILITY(U,$J,358.3,22789,2)
 ;;=^5000605
 ;;^UTILITY(U,$J,358.3,22790,0)
 ;;=B35.6^^76^979^5
 ;;^UTILITY(U,$J,358.3,22790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22790,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,22790,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,22790,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,22791,0)
 ;;=B35.3^^76^979^8
 ;;^UTILITY(U,$J,358.3,22791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22791,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,22791,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,22791,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,22792,0)
 ;;=B35.4^^76^979^4
 ;;^UTILITY(U,$J,358.3,22792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22792,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,22792,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,22792,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,22793,0)
 ;;=L51.2^^76^979^11
 ;;^UTILITY(U,$J,358.3,22793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22793,1,3,0)
 ;;=3^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,22793,1,4,0)
 ;;=4^L51.2
 ;;^UTILITY(U,$J,358.3,22793,2)
 ;;=^5009206
 ;;^UTILITY(U,$J,358.3,22794,0)
 ;;=B35.0^^76^979^2
 ;;^UTILITY(U,$J,358.3,22794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22794,1,3,0)
 ;;=3^Tinea Barae/Capitis
 ;;^UTILITY(U,$J,358.3,22794,1,4,0)
 ;;=4^B35.0
 ;;^UTILITY(U,$J,358.3,22794,2)
 ;;=^5000604
 ;;^UTILITY(U,$J,358.3,22795,0)
 ;;=B36.3^^76^979^3
 ;;^UTILITY(U,$J,358.3,22795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22795,1,3,0)
 ;;=3^Tinea Blanca
 ;;^UTILITY(U,$J,358.3,22795,1,4,0)
 ;;=4^B36.3
 ;;^UTILITY(U,$J,358.3,22795,2)
 ;;=^266864
 ;;^UTILITY(U,$J,358.3,22796,0)
 ;;=B36.1^^76^979^7
 ;;^UTILITY(U,$J,358.3,22796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22796,1,3,0)
 ;;=3^Tinea Nigra
 ;;^UTILITY(U,$J,358.3,22796,1,4,0)
 ;;=4^B36.1
 ;;^UTILITY(U,$J,358.3,22796,2)
 ;;=^264999
 ;;^UTILITY(U,$J,358.3,22797,0)
 ;;=B36.0^^76^979^10
 ;;^UTILITY(U,$J,358.3,22797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22797,1,3,0)
 ;;=3^Tinea Veriscolor
 ;;^UTILITY(U,$J,358.3,22797,1,4,0)
 ;;=4^B36.0
 ;;^UTILITY(U,$J,358.3,22797,2)
 ;;=^5000608
 ;;^UTILITY(U,$J,358.3,22798,0)
 ;;=L81.8^^76^979^1
 ;;^UTILITY(U,$J,358.3,22798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22798,1,3,0)
 ;;=3^Tattoo Pigmentation
 ;;^UTILITY(U,$J,358.3,22798,1,4,0)
 ;;=4^L81.8
 ;;^UTILITY(U,$J,358.3,22798,2)
 ;;=^5009318
 ;;^UTILITY(U,$J,358.3,22799,0)
 ;;=L80.^^76^980^12
